Elevance Health

ELV Health Care Market cap $91.5B as of Oct 29, 2026 16:00 ET S&P 500

Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 21, 2026

Revenue$51.43B +1% year over year

Gross profit$45.79B 89% margin

Operating profit$1.27B 2% margin

Net profit$1.37B 3% margin

Net profit is larger than what operations earned, because the statement adds $0.55B below it, under Other income, net.

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Sep 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	51.43	100%	+1%
Health benefits	43.36	84%	+3%
Carelon services	7.71	15%	+5%
Other revenue	0.36	1%
Corporate & other	0.01	0%	−96%
Cost of revenue	−5.64	11%
Gross profit	45.79	89% margin	+0pp
SG&A	−5.75	11%	+1pp
Other	−38.77	76%	+0pp
Operating profit	1.27	2% margin
Other income, net	0.55
Tax	−0.45
Net profit	1.37	3% margin

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	50.5	100%	+1%
Cost of revenue	−5.5	11%
Gross profit	45.0	89% margin	+0pp
SG&A	−5.5	11%	+1pp
Other	−37.7	75%	+0pp
Operating profit	1.8	3% margin	−1pp
Other income, net	0.2
Tax	−0.5
Net profit	1.5	3% margin	−1pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	49.75	100%	+10%
Cost of revenue	−5.52	11%
Gross profit	44.23	89% margin	+2pp
SG&A	−5.42	11%	+0pp
Other	−38.50	77%
Operating profit	0.31	1% margin	−1pp
Interest & other costs	−0.09
Tax benefit	0.33
Net profit	0.55	1% margin	+0pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	50.71	100%	+12%
Health benefits	42.25	83%
Carelon services	7.32	15%
Other revenue	0.99	2%
Corporate & other	0.15	0%
Cost of revenue	−5.38	11%
Gross profit	45.33	89% margin	+1pp
SG&A	−5.27	10%	−1pp
Other	−38.76	77%	+0pp
Operating profit	1.30	3% margin	−1pp
Other income, net	0.11
Tax	−0.22
Net profit	1.19	2% margin	+0pp

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	49.78	100%	+13%
Health benefits	41.58	84%
Carelon services	7.44	15%
Other revenue	0.52	1%
Corporate & other	0.23	0%
Cost of revenue	−5.29	11%
Gross profit	44.48	89% margin	+0pp
SG&A	−5.00	10%	−2pp
Other	−37.06	74%	+0pp
Operating profit	2.43	5% margin	−1pp
Interest & other costs	−0.13
Tax	−0.55
Net profit	1.74	4% margin	−2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY24 (period ends Dec 31, 2024).
Item	Value	Share of revenue	Year over year
Revenue	45.4	100%	+7%
CarelonRx	36.0	79%
Health Benefits	7.6	17%
Carelon Services	0.8	2%
Other revenue	0.8	2%
Corporate & Other	0.3	0%
Other and unallocated	−0.1	0%
Cost of revenue	−6.0	13%
Gross profit	39.4	87% margin	−2pp
SG&A	−4.8	10%	−1pp
Other	−34.0	75%	+0pp
Operating profit	0.7	1% margin	−2pp
Interest & other costs	−0.1
Tax	−0.2
Net profit	0.4	1% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 21, 2026 Operating margin 2% Net profit $1.37B	Jul 1 – Sep 30, 2026	Oct 21, 2026	$51.4B	+1%	2%	$1.37B	3%
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 15, 2026 Operating margin 3% Net profit $1.46B	Apr 1 – Jun 30, 2026	Jul 15, 2026	$50.5B	+1%	3%	$1.46B	3%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 6, 2026 Operating margin 1% Net profit $0.55B	Oct 1 – Dec 31, 2025	Feb 6, 2026	$49.7B	+10%	1%	$0.55B	1%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 21, 2025 Operating margin 3% Net profit $1.19B	Jul 1 – Sep 30, 2025	Oct 21, 2025	$50.7B	+12%	3%	$1.19B	2%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Jul 17, 2025 Operating margin 5% Net profit $1.74B	Apr 1 – Jun 30, 2025	Jul 17, 2025	$49.8B	+13%	5%	$1.74B	4%
Q4 FY24 Oct 1 – Dec 31, 2024 reported Feb 20, 2025 Operating margin 1% Net profit $0.40B	Oct 1 – Dec 31, 2024	Feb 20, 2025	$45.4B	+7%	1%	$0.40B	1%